Fiddler Morris
DePaul University and Insight Medical Genetics, LLC 680 N, Lake Shore Drive Chicago, IL 60611, USA.
J Clin Med. 2014 Sep 5;3(3):972-85. doi: 10.3390/jcm3030972.
The ability to capture and analyze fetal cells from maternal circulation or other sources during pregnancy has been a goal of prenatal diagnostics for over thirty years. The vision of replacing invasive prenatal diagnostic procedures with the prospect of having the entire fetal genome in hand non-invasively for chromosomal and molecular studies for both clinical and research use has brought many investigators and innovations into the effort. While the object of this desire, however, has remained elusive, the aspiration for this approach to non-invasive prenatal diagnosis remains and the inquiry has continued. With the advent of screening by cell-free DNA analysis, the standards for fetal cell based prenatal diagnostics have been sharpened. Relevant aspects of the history and the current status of investigations to meet the goal of having an accessible and reliable strategy for capturing and analyzing fetal cells during pregnancy are reviewed.
在孕期从母体循环或其他来源捕获并分析胎儿细胞的能力,三十多年来一直是产前诊断的目标。用非侵入性方法获取完整胎儿基因组以用于临床和研究的染色体及分子研究,从而取代侵入性产前诊断程序的愿景,吸引了众多研究者并催生了许多创新成果。然而,尽管这一愿望的目标仍难以实现,但对这种非侵入性产前诊断方法的渴望依然存在,相关探索也在继续。随着游离DNA分析筛查的出现,基于胎儿细胞的产前诊断标准更加严格。本文回顾了为实现孕期捕获和分析胎儿细胞的可及且可靠策略这一目标的研究历史及现状的相关方面。